These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 15050913)

  • 61. Opposite roles of human pancreatitis-associated protein and REG1A expression in hepatocellular carcinoma: association of pancreatitis-associated protein expression with low-stage hepatocellular carcinoma, beta-catenin mutation, and favorable prognosis.
    Yuan RH; Jeng YM; Chen HL; Hsieh FJ; Yang CY; Lee PH; Hsu HC
    Clin Cancer Res; 2005 Apr; 11(7):2568-75. PubMed ID: 15814635
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, beta-catenin expression, and clinical features.
    Wei Y; Van Nhieu JT; Prigent S; Srivatanakul P; Tiollais P; Buendia MA
    Hepatology; 2002 Sep; 36(3):692-701. PubMed ID: 12198663
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Lithium-mediated downregulation of PKB/Akt and cyclin E with growth inhibition in hepatocellular carcinoma cells.
    Erdal E; Ozturk N; Cagatay T; Eksioglu-Demiralp E; Ozturk M
    Int J Cancer; 2005 Jul; 115(6):903-10. PubMed ID: 15723355
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Suppression of beta-catenin mutation by dietary exposure of auraptene, a citrus antioxidant, in N,N-diethylnitrosamine-induced hepatocellular carcinomas in rats.
    Hara A; Sakata K; Yamada Y; Kuno T; Kitaori N; Oyama T; Hirose Y; Murakami A; Tanaka T; Mori H
    Oncol Rep; 2005 Aug; 14(2):345-51. PubMed ID: 16012713
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cyclin D1 over-expression correlates with beta-catenin activation, but not with H-ras mutations, and phosphorylation of Akt, GSK3 beta and ERK1/2 in mouse hepatic carcinogenesis.
    Gotoh J; Obata M; Yoshie M; Kasai S; Ogawa K
    Carcinogenesis; 2003 Mar; 24(3):435-42. PubMed ID: 12663502
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Hepatocellular carcinoma.
    Ahn J; Flamm SL
    Dis Mon; 2004 Oct; 50(10):556-73. PubMed ID: 15616490
    [No Abstract]   [Full Text] [Related]  

  • 67. Hepatocarcinogenesis in mice with beta-catenin and Ha-ras gene mutations.
    Harada N; Oshima H; Katoh M; Tamai Y; Oshima M; Taketo MM
    Cancer Res; 2004 Jan; 64(1):48-54. PubMed ID: 14729607
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Beta-catenin and its mRNA in renal cell carcinoma].
    Zang T; Zhuang L; Zhang Z; Xin D; Guo Y
    Zhonghua Wai Ke Za Zhi; 2000 Jan; 38(1):37-9. PubMed ID: 11831984
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Beta-catenin accumulation and mutation of the CTNNB1 gene in hepatoblastoma.
    Bläker H; Hofmann WJ; Rieker RJ; Penzel R; Graf M; Otto HF
    Genes Chromosomes Cancer; 1999 Aug; 25(4):399-402. PubMed ID: 10398436
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Hepatocellular carcinoma.
    Lau WY; Leow CK; Li AK
    Br J Hosp Med; 1997 Feb 5-18; 57(3):101-4. PubMed ID: 9196588
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Regulating the regulators: routing the Wnt-beta-catenin--Lef signals.
    Widelitz RB
    J Invest Dermatol; 2004 Aug; 123(2):VIII-X. PubMed ID: 15245452
    [No Abstract]   [Full Text] [Related]  

  • 72. SMAF-1 inhibits the APC/beta-catenin pathway and shows properties similar to those of the tumor suppressor protein APC.
    Karaguni IM; Gourzoulidou E; Carpintero M; Langerak A; Klein-Hitpass L; Möröy T; Winde G; Waldmann H; Müller O
    Chembiochem; 2004 Sep; 5(9):1267-70. PubMed ID: 15368578
    [No Abstract]   [Full Text] [Related]  

  • 73. Beta-catenin mutations are frequent in hepatocellular carcinomas but absent in adenomas induced by diethylnitrosamine in B6C3F1 mice.
    Ogawa K; Yamada Y; Kishibe K; Ishizaki K; Tokusashi Y
    Cancer Res; 1999 Apr; 59(8):1830-3. PubMed ID: 10213486
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Diagnosis and treatment of hepatocellular carcinoma.
    Suarez Y; Sala M; Llovet JM; Bruix J
    Acta Gastroenterol Belg; 1999; 62(4):410-4. PubMed ID: 10692771
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Liver and hepatic duct cancer.
    Valea FA
    Clin Obstet Gynecol; 2002 Sep; 45(3):939-51. PubMed ID: 12370634
    [No Abstract]   [Full Text] [Related]  

  • 76. Activation of the beta-catenin gene in primary hepatocellular carcinomas by somatic alterations involving exon 3.
    Miyoshi Y; Iwao K; Nagasawa Y; Aihara T; Sasaki Y; Imaoka S; Murata M; Shimano T; Nakamura Y
    Cancer Res; 1998 Jun; 58(12):2524-7. PubMed ID: 9635572
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Coordinated expression of cyclin D1 and LEF-1/TCF transcription factor is restricted to a subset of hepatocellular carcinoma.
    Schmitt-Graeff A; Ertelt-Heitzmann V; Allgaier HP; Olschewski M; Nitschke R; Haxelmans S; Koelble K; Behrens J; Blum HE
    Liver Int; 2005 Aug; 25(4):839-47. PubMed ID: 15998435
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Genetic alterations in hepatocellular carcinomas: associations with clinical parameters].
    Bluteau O; Laurent-Puig P; Zucman-Rossi J
    Gastroenterol Clin Biol; 2001 Dec; 25(12):1067-77. PubMed ID: 11910987
    [No Abstract]   [Full Text] [Related]  

  • 79. Phosphorylation of beta-catenin at S33, S37, or T41 can occur in the absence of phosphorylation at T45 in colon cancer cells.
    Wang Z; Vogelstein B; Kinzler KW
    Cancer Res; 2003 Sep; 63(17):5234-5. PubMed ID: 14500351
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Overexpression of Icat induces G(2) arrest and cell death in tumor cell mutants for adenomatous polyposis coli, beta-catenin, or Axin.
    Sekiya T; Nakamura T; Kazuki Y; Oshimura M; Kohu K; Tago K; Ohwada S; Akiyama T
    Cancer Res; 2002 Jun; 62(11):3322-6. PubMed ID: 12036951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.